Echo Pharmaceuticals is a formulation company focussed on cannabinoids-based medicines. Echo developed a platform technology to administer lipophilic compounds. Through our patented production process, Echo is able to produce and develop pharmaceutical products.
Echo Pharmaceuticals has developed Namisol which is the first sublingual tablet containing ultra-pure THC.
Read our Namisol® press release and the latest press release about medicinal cannabis (in Dutch) (nov 7, 2007).
January 23rd 2008: Echo-Pharmaceuticals announces funding for clinical studies (press release)